175 related articles for article (PubMed ID: 30172970)
1. Prognostic Factors and Survival of Gliomatosis Cerebri: A Systematic Review and Meta-Analysis.
Georgakis MK; Tsivgoulis G; Spinos D; Liaskas A; Herrlinger U; Petridou ET
World Neurosurg; 2018 Dec; 120():e818-e854. PubMed ID: 30172970
[TBL] [Abstract][Full Text] [Related]
2. Gliomatosis Cerebri Among Children and Adolescents: An Individual-Patient Data Meta-analysis of 182 Patients.
Georgakis MK; Tsivgoulis G; Pourtsidis A; Petridou ET
J Child Neurol; 2019 Jun; 34(7):394-401. PubMed ID: 30887873
[TBL] [Abstract][Full Text] [Related]
3. Gliomatosis cerebri: no evidence for a separate brain tumor entity.
Herrlinger U; Jones DTW; Glas M; Hattingen E; Gramatzki D; Stuplich M; Felsberg J; Bähr O; Gielen GH; Simon M; Wiewrodt D; Schabet M; Hovestadt V; Capper D; Steinbach JP; von Deimling A; Lichter P; Pfister SM; Weller M; Reifenberger G
Acta Neuropathol; 2016 Feb; 131(2):309-319. PubMed ID: 26493382
[TBL] [Abstract][Full Text] [Related]
4. Gliomatosis cerebri: clinical characteristics, management, and outcomes.
Chen S; Tanaka S; Giannini C; Morris J; Yan ES; Buckner J; Lachance DH; Parney IF
J Neurooncol; 2013 Apr; 112(2):267-75. PubMed ID: 23341100
[TBL] [Abstract][Full Text] [Related]
5. Incidence and survival of gliomatosis cerebri: a population-based cancer registration study.
Georgakis MK; Spinos D; Pourtsidis A; Psyrri A; Panourias IG; Sgouros S; Petridou ET
J Neurooncol; 2018 Jun; 138(2):341-349. PubMed ID: 29464663
[TBL] [Abstract][Full Text] [Related]
6. Wide Range of Clinical Outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A Clinical, Radiographic, and Histopathologic Study.
Ly KI; Oakley DH; Pine AB; Frosch MP; Chiou SH; Betensky RA; Pomerantz SR; Hochberg FH; Batchelor TT; Cahill DP; Dietrich J
Oncologist; 2019 Mar; 24(3):402-413. PubMed ID: 30097523
[TBL] [Abstract][Full Text] [Related]
7. Gliomatosis cerebri: 20 years of experience at the Children's Hospital of Philadelphia.
Armstrong GT; Phillips PC; Rorke-Adams LB; Judkins AR; Localio AR; Fisher MJ
Cancer; 2006 Oct; 107(7):1597-606. PubMed ID: 16955507
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for overall survival in surgical cases of gliomatosis cerebri from the National Cancer Database.
Khalafallah AM; Kopparapu S; Mukherjee D
J Clin Neurosci; 2020 Nov; 81():186-191. PubMed ID: 33222914
[TBL] [Abstract][Full Text] [Related]
9. NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.
Glas M; Bähr O; Felsberg J; Rasch K; Wiewrodt D; Schabet M; Simon M; Urbach H; Steinbach JP; Rieger J; Fimmers R; Bamberg M; Nägele T; Reifenberger G; Weller M; Herrlinger U;
Ann Neurol; 2011 Sep; 70(3):445-53. PubMed ID: 21710625
[TBL] [Abstract][Full Text] [Related]
10. Clinical, neuroimaging and histopathological features of gliomatosis cerebri: a systematic review based on synthesis of published individual patient data.
Georgakis MK; Tsivgoulis G; Spinos D; Dimitriou NG; Kyritsis AP; Herrlinger U; Petridou ET
J Neurooncol; 2018 Nov; 140(2):467-475. PubMed ID: 30117023
[TBL] [Abstract][Full Text] [Related]
11. Relationship between treatment effects on progression-free survival and overall survival in multiple myeloma: a systematic review and meta-analysis of published clinical trial data.
Cartier S; Zhang B; Rosen VM; Zarotsky V; Bartlett JB; Mukhopadhyay P; Wagner S; Davis C
Oncol Res Treat; 2015; 38(3):88-94. PubMed ID: 25792079
[TBL] [Abstract][Full Text] [Related]
12. Gliomatosis cerebri (GC) or GC-like? A picture to be reconsidered in neuro-oncology based on large retrospective analysis of GC series.
Anghileri E; Schettino C; Pollo B; Farinotti M; Silvani A; Paterra R; Patanè M; DiMeco F; Bruzzone MG; Eoli M; Cuccarini V
Neurol Sci; 2020 Aug; 41(8):2111-2120. PubMed ID: 32114667
[TBL] [Abstract][Full Text] [Related]
13. Gliomatosis cerebri having a poor performance status without recurrence after radiotherapy: a single institutional experience.
Jung TY; Yoon MS; Kim YH; Jung S; Kim IY; Jang WY; Moon KS; Lee KH; Kim SK
Clin Neurol Neurosurg; 2015 Mar; 130():1-5. PubMed ID: 25569296
[TBL] [Abstract][Full Text] [Related]
14. Gliomatosis cerebri: a review of 22 cases.
Vates GE; Chang S; Lamborn KR; Prados M; Berger MS
Neurosurgery; 2003 Aug; 53(2):261-71; discussion 271. PubMed ID: 12925240
[TBL] [Abstract][Full Text] [Related]
15. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis.
Sun L; Ma JT; Zhang SL; Zou HW; Han CB
Med Oncol; 2015 Feb; 32(2):473. PubMed ID: 25603953
[TBL] [Abstract][Full Text] [Related]
17. Leptomeningeal Gliomatosis: A Single Institution Study of 31 Patients.
Autran D; Barrie M; Matta M; Monserrat C; Campello C; Petrirena G; Boucard C; Padovani L; Loundou A; Appay R; Graillon T; Dufour H; Figarella-Branger D; Chinot O; Tabouret E
Anticancer Res; 2019 Feb; 39(2):1035-1041. PubMed ID: 30711992
[TBL] [Abstract][Full Text] [Related]
18. Surrogacy of progression free survival for overall survival in metastatic breast cancer studies: Meta-analyses of published studies.
Kundu MG; Acharyya S
Contemp Clin Trials; 2017 Feb; 53():20-28. PubMed ID: 27940185
[TBL] [Abstract][Full Text] [Related]
19. Gliomatosis cerebri: treatment results with radiotherapy alone.
Elshaikh MA; Stevens GH; Peereboom DM; Cohen BH; Prayson RA; Lee SY; Barnett GH; Suh JH
Cancer; 2002 Nov; 95(9):2027-31. PubMed ID: 12404298
[TBL] [Abstract][Full Text] [Related]
20. Gliomatosis Cerebri Growth Pattern: Association of Differential First-Line Treatment with Overall Survival in WHO Grade II and III Gliomas.
Divé I; Steidl E; Wagner M; Filipski K; Burger MC; Franz K; Harter PN; Bähr O; Fokas E; Herrlinger U; Steinbach JP
Oncology; 2021; 99(4):215-224. PubMed ID: 33472203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
